Medtronic, 3M, Abbott Labs, Oh My! Transfer Pricing Update
Tax Notes contributing editor Ryan Finley discusses the latest developments in three transfer pricing cases — Medtronic, 3M, and Abbott Labs — and their implications for the future.
For additional coverage, read these articles in Tax Notes:
- Business Groups Urge Eighth Circuit to Overturn Tax Court in 3M
- Medtronic Budges on CUT Method in Round 2 at Eighth Circuit
- Abbott Labs Revives Fight Over Stock Options in Transfer Pricing
- Blocked Brazilian Income Can’t Be Taxed in U.S., 3M Brief Argues
- 3M Challenges Blocked Income Regs at Eighth Circuit
- Government Resumes Defense of Its Transfer Pricing for Medtronic
- Coca-Cola’s Brazilian Income Not Blocked, U.S. Tax Court Says
In our “Editors’ Corner” segment, Edith Brashares, former director in the Treasury Office of Tax Analysis, chats about her coauthored Tax Notes piece, “Is the Economic Analysis Section of Regs Worth the Trouble?”
Follow us on Twitter:
**
This episode is sponsored by the University of California Irvine School of Law Graduate Tax Program. For more information, visit law.uci.edu/gradtax.
***
Credits
Host: David D. Stewart
Executive Producers: Jasper B. Smith, Paige Jones
Showrunner: Jordan Parrish
Audio Engineers: Jordan Parrish, Peyton Rhodes
Guest Relations: Alexis Hart